M
Martin T. Rothman
Researcher at Queen Mary University of London
Publications - 121
Citations - 3327
Martin T. Rothman is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Stent & Percutaneous coronary intervention. The author has an hindex of 27, co-authored 120 publications receiving 3084 citations. Previous affiliations of Martin T. Rothman include Stanford University & Barts Health NHS Trust.
Papers
More filters
Journal ArticleDOI
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend,Felix Mahfoud,Felix Mahfoud,David E. Kandzari,Kazuomi Kario,Stuart J. Pocock,Michael A. Weber,Sebastian Ewen,Konstantinos Tsioufis,Dimitrios Tousoulis,Andrew S.P. Sharp,A. Watkinson,Roland E. Schmieder,Axel Schmid,James W. Choi,Cara East,Anthony Walton,Ingrid Hopper,Debbie L. Cohen,Robert L. Wilensky,David P. Lee,Adrian Ma,Chandan Devireddy,Janice P. Lea,Philipp Lurz,Karl Fengler,Justin E. Davies,Neil Chapman,Sidney Cohen,Vanessa DeBruin,Martin Fahy,Denise E Jones,Martin T. Rothman,Michael Böhm,Jiro Aoki,Bryan Batson,George Dangas,Shukri David,David E. Kandzari,Manesh R. Patel,Kiritkumar Patel,Jasvindar Singh,Thomas Weber,Joachim Weil,Thomas Zeller,Khaled M. Ziada,Kengo Tanabe,Robert Wilkins,Johanna Contreras,Susan Steigerwalt,Denise Reedus,Satoshi Hoshide,Laura P. Svetkey,Anjani Rao,Angela L. Brown,Markus Suppan,Tolga Agdirlioglu,Elias Noory,Craig Chasen +58 more
TL;DR: Results from SPYRAL HTN-OFF MED provide biological proof of principle for the blood-pressure-lowering efficacy of renal denervation in the absence of antihypertensive medications.
Journal ArticleDOI
Intravascular ultrasound-guided optimized stent deployment Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)
P. de Jaegere,Harald Mudra,H. R. Figulla,Yaron Almagor,S. Doucet,Ian M. Penn,Antonio Colombo,Christian W. Hamm,Antonio L. Bartorelli,Martin T. Rothman,Masakiyo Nobuyoshi,T. Yamaguchi,Vassilis Voudris,C. DiMario,S. Makovski,Dirk Hausmann,S. Rowe,S. Rabinovich,Madoka Sunamura,G.A. van Es +19 more
TL;DR: These data confirm that, in selected patients, stents can safely be implanted without the use of systemic anticoagulation, provided optimal stent expansion is achieved.
Journal ArticleDOI
Successful Recanalization of Chronic Total Occlusions Is Associated With Improved Long-Term Survival
Daniel A. Jones,Roshan Weerackody,Krishnaraj S. Rathod,Jonathan M. Behar,Sean Gallagher,Charles Knight,Charles Knight,Akhil Kapur,Ajay K. Jain,Ajay K. Jain,Martin T. Rothman,Martin T. Rothman,Craig A. Thompson,Anthony Mathur,Anthony Mathur,Andrew Wragg,Andrew Wragg,Elliot J. Smith,Elliot J. Smith +18 more
TL;DR: Successful CTO PCI is associated with improved survival out to 5 years and adoption of techniques and technologies to improve procedural success may have an impact on prognosis.
Journal ArticleDOI
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation
Sigmund Silber,Ajay J. Kirtane,Jorge Belardi,Minglei Liu,Sandeep Brar,Martin T. Rothman,Stephan Windecker +6 more
TL;DR: Dual antiplatelet therapy interruptions between 1 and 12 months were associated with low rates of stent thrombosis and adverse cardiac outcomes and Randomized clinical trials are needed to determine whether early temporary or permanent interruption of DAPT is truly safe.
Journal ArticleDOI
Improved catheter for regional coronary sinus flow and metabolic studies.
TL;DR: An improved coronary sinus catheter has been developed whose enhanced flexibility facilitates catheterization of the great cardiac vein, and it allows simultaneous thermodilution measurement of blood flow in the great heart vein and proximal coronary Sinus.